21 May 2013
Keywords: psi, launched, improve, conditions, schizophrenia, patients, five
Article | 09 December 1999
Five major drugmakers that are active in the field of schizophrenia(AstraZeneca, Eli Lilly, Janssen-Cilag, Novartis and Pfizer) have joined
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
9 December 1999
20 May 2013
© 2013 thepharmaletter.com